Homepage | Forward to a Friend | Make a Donation |
|
eLetter #739 | December 1, 2017 |
|
|
Video: Frequently Asked Questions
Maureen D. Mayes, M.D., discusses the following points and take questions from the audience at the Scleroderma Foundation's 2017 Patient Education Conference. 1) How many cases of scleroderma are there and is this changing over time? 2) Clinical update on current and future therapy. 3) Research update on finding the cause and cure. 4) Success stories from the Scleroderma Foundation’s Research Grant program – past, current, and future.
watch video
|
|
Open Enrollment Ends Dec. 15 for 2018 Health Insurance Under ACA
If you need health insurance for 2018 via the individual marketplace of the Affordable Care Act, the open enrollment period is now through December 15. Anyone who doesn't have coverage through a job, Medicare, Medicaid, the Children's Health Insurance Plan (CHIP), or other qualifying coverage is eligible to apply. Visit the HealthCare.gov website to learn more and sign up.
HealthCare.gov
|
|
Grassroots Advocacy Training
Public policy advocacy on behalf of people affected by scleroderma at both the state and federal level is crucial to making a difference in their lives. The Scleroderma Foundation now offers monthly grassroots advocacy training webinars.
|
|
8 Ways to Stay Healthy this Winter
It takes more than hand-washing. Here’s an easy guide to preventing infection.
|
|
Stress, Depression and the Holidays: Tips for Coping
By Mayo Clinic Staff
Stress and depression can ruin your holidays and hurt your health. Being realistic, planning ahead and seeking support can help ward off stress and depression. read more
|
|
Journal of Scleroderma and Related Disorders
The Journal of Scleroderma and Related Disorders is an international, multi-disciplinary, peer-reviewed publication targeted to scientists and clinicians interested in systemic sclerosis, scleroderma, and other related autoimmune and fibrotic diseases. The journal publishes high quality, original research articles on the epidemiology, natural history, pathophysiology, diagnosis, treatment and outcome of these diseases as well as reviews and thought-provoking editorials and commentaries.
read more
|
|
2018 National Patient Education Conference
Sign up for e-Alerts to stay up to date on the 2018 National Patient Education Conference in Philadelphia, Pennsylvania, July 27-29.
sign up for e-alerts
|
|
Support - Education - Research
Together, we make a difference for thousands of people affected by scleroderma. For the person who is newly diagnosed and looking for reliable answers, for the caregiver who is seeking advice on how to better help their loved one, for those living with scleroderma advocating for a better quality of life, and for all who share the common hope of finding a cure, we make a difference when we stand together.
The scleroderma community needs you now more than ever. Please make this a season of hope by taking action to eliminate scleroderma and making a year-end gift today to the Scleroderma Foundation.
|
|
|
|
|
|
Disclaimer: The Scleroderma Foundation in no way
endorses any drugs, treatments, clinical trials, or studies reported in the eLetter. Information is
provided to keep the readers informed. Because the manifestations and severity of scleroderma vary among individuals, personalized medical management is essential. Therefore, it is strongly recommended that all drugs and treatments be discussed with the reader’s physician(s) for proper evaluation and treatment.
|
|
|